Patent ID: 6759422
Filing Date: 2004-07-06
Classification: A61P,C07D

Abstract:
A method of treatment or alleviation of a disease or a disorder or a condition of a living animal body, comprising the step ofadministering to such a living animal body in need thereof a therapeutically effective amount of a benzothiazole compound represented by Formula IV â€ƒor a pharmaceutically acceptable salt, oxide or hydrate thereof, wherein, Râ€²â€³ and Râ€³â€³, independently of each other, represent hydrogen or alkyl; R1 and R2, independently of each other, represent hydrogen, alkyl, alkoxy, cycloalkyl, amino, halogen, trihalogenmethyl, nitro, or cyano; or R1 and R2, together form a mono- or poly-carbocyclic group, which may optionally be substituted one or more times with substituents selected from the group consisting of halogen, trihalogenmethyl, alkyl, alkoxy, amino, nitro, and cyano wherein said disease or a disorder or condition is urinary incontinence.